Irreversible end-stage cardiomyopathy following a single dose of cyclophosphamide.
Heart Failure and Pulmonary Hypertension Program, Heart and Vascular Center, Hackensack University Medical Center, Hackensack, NJ, USA. zerangi@hotmail.com
Sina
S
Dadfarmay
Robert
R
Berkowitz
Bernard
B
Kim
D009202:Cardiomyopathies / Q000139:chemically induced*; D003520:Cyclophosphamide / Q000009:adverse effects*; D005260:Female; D005921:Glomerulonephritis; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008875:Middle Aged
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide